Abstract
Esophageal cancer (EC) is the sixth most common cause of cancer-related mortality, contributing to significant economic burden for patients and caregivers. Cost of illness studies, which are useful tools for policymakers, vary in the burden reported due to methodological differences. This study aims to systematically summarize available evidence on the economic burden of EC and describes the methods and data sources utilized.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
